The field of exposure science began with qualitative observations and quantitative measurements of air contaminants to aid our understanding of exposure--disease relationships. In fact, some of the earliest writings that describe the essence of exposure science are found in Bernardino Ramazzini's 1700 treatise on occupational diseases ([@r4]). In the 1920s, exposure scientists collaborated with epidemiologists to investigate workplace exposures as sources of occupational diseases ([@r17]). Between the 1950s and 1970, investigations expanded to include exposures to pollutants in ambient and indoor air and water ([@r17]). Following establishment of U.S. governmental agencies in the 1970s to regulate exposures in the workplace (Occupational Safety and Health Administration) and the ambient environment \[U.S. Environmental Protection Agency (EPA)\], the paths of exposure scientists diverged into those investigating sources of pollutants in occupational settings and those investigating ambient sources of pollutants ([@r17]). By the 1990s the two groups had essentially parted ways, and the term "exposure science" was associated with community and personal exposures to ambient pollutants ([@r11]; [@r14], [@r15]). Investigations of total personal exposure initially employed external measurements of chemicals that can enter the body by inhalation, ingestion, and dermal contact (1970s), and internal markers of exposure were added in the 1980s and 1990s ([@r2]; [@r8]; [@r19]; [@r20]). In the 21st century, exposure science has increasingly embraced deterministic models to predict levels of diverse exposures based on categorical data ([@r3]; [@r5]; [@r11]) and on measured levels of pollutants in biological fluids and tissues ([@r6]).

In parallel with the above activities, during the 1980s and 1990s, molecular epidemiologists explored links between genetic and environmental factors and the resulting biochemical or biological indicators of possible ill health (biomarkers) measured in individual subjects ([@r1]). When completion of the human genome project in 2000 made it feasible to measure thousands of polymorphic genes in each subject, epidemiology increasingly focused on the genetic determinants of diseases ([@r7]). However, as results of these genome-wide association studies (GWAS) failed to explain most variability in human diseases ([@r12]), interest in environmental factors reemerged. But there was no environmental analog of GWAS; that is, we had no way of characterizing the totality of a person's environmental exposures. This prompted Christopher Wild to publish a commentary that defined the "exposome" as the environmental complement to the genome ([@r22]). Recognizing that humans are exposed to health-impairing agents from both pollution and nonpollution sources and that these sources change during a lifetime, Wild indicated that "... the exposome encompasses life-course environmental exposures (including lifestyle factors) from the prenatal period onwards." This is a powerful idea because it considers a person's lifetime history of all exposures experienced from both external sources (e.g. pollution, radiation, and diet) and internal sources (e.g. inflammation, infection, and the microbiome) ([@r18]). Thus, one can imagine a future in which individuals' exposomes are contrasted between diseased and healthy populations for molecular epidemiology, or over different life stages as part of personalized medicine ([@r13]). In either case, the goal would be to discover causes of ill health and to generate hypotheses regarding identification and elimination or reduction of harmful exposures.

If the exposome concept is to be useful to exposure science, methods will be needed to characterize individual exposomes and to investigate sources of exposome variability. Because exposures arise from diverse sources, Rappaport defined two generic approaches for characterizing exposomes ([@r17]; [@r18]). A "bottom-up" approach would focus on each category of external exposure---including air, water, diet, radiation, lifestyle, etc.---to quantify contaminant levels that would be summed over all categories to estimate individual exposomes. This approach is appealing to some exposure scientists because it focuses on the same external media that have long been investigated and leads logically to interventions for eliminating or reducing exposures. However, this bottom-up approach would require tremendous effort to evaluate the myriad of largely unknown analytes in various external media and would also miss important endogenous exposures. The alternative "top-down" approach would adopt untargeted omic methods to measure features of exposures in biological fluids, and thus finds appeal with exposure scientists who have used biomonitoring for assessing exposure levels, albeit on a chemical-by-chemical basis. This approach is more efficient because both exogenous and endogenous exposures would be represented by a single specimen of blood, for example, and would encourage contrasts of omic profiles between diseased and healthy populations in much the same manner as GWAS ([@r16]). Omic profiles would generate hypotheses to *a*) indentify particular exposures, *b*) develop specific biomarkers for high-throughput screens, and *c*) determine sources of external and internal exposure. Recent untargeted metabolomic studies have applied this top-down approach to identify hitherto unknown exposures associated with cardiovascular disease ([@r9]; [@r21]).

When examined objectively, there is scientific value in both the bottom-up and top-down approaches for characterizing individual exposomes. The top-down approach offers appeal for discovering unknown causes of human disease ([@r17]; [@r18]), whereas the bottom-up approach encourages more comprehensive analyses of external exposures and methods for intervention and prevention ([@r11]). Indeed, we envision long-term strategies that embrace elements of both approaches for improving public health. Unfortunately, the differentiation between external (air, water, soil/dust, etc.) and internal (biological fluids) media has led to an apparent disconnect or competition between exposure scientists who focus on external monitoring and modeling and those who favor biomonitoring and omic methods. Indeed, we are encountering a view that can be summarized as "exposure science versus the exposome." This is counterproductive because it potentially deprives exposure science of avenues for vastly diversifying its pool of relevant exposures and for strengthening the source-to-dose framework needed by the environmental health sciences. Rather than adopting defensive postures, we encourage exposure scientists to exploit the relative strengths of both monitoring approaches for assessing human exposures. Toward this end, the National Academy of Sciences will convene a workshop in December 2011 to better integrate the top-down and bottom-up approaches for characterizing individual exposomes (Emerging Technologies for Measuring Individual Exposomes, 8--9 December 2011, Washington, DC; information is available at <http://dels.nas.edu/envirohealth>).

Other recent developments offer opportunities for exposure scientists to characterize individual exposomes. For example, the National Children's Study ([@r10]) offers an evolving platform with which to link the top-down and bottom-up approaches. Because individual data and biospecimens will be collected during the first 21 years of life, this study will provide resources that can be used to evaluate the variability of exposome features during critical life stages. Moreover, the extensive questionnaire data, home samples, extant environmental data, and dietary histories of participants suggest avenues for modeling connections between the internal and external environments. Such prospective cohort studies will allow us to collect more and better exposure data with which to identify unknown health hazards and to develop appropriate preventive measures and regulations for recognized hazards. The exposome concept can play a key role in both endeavors.

The authors declare they have no actual or potential competing financial interests.

[^1]: *Paul J. Lioy is a professor of environmental and occupational medicine and director of exposure science at Robert Wood Johnson Medical School--UMDNJ and Deputy Director for Government Relations at the Environmental and Occupational Health Sciences Institute, Piscataway, New Jersey. He was the 1998 recipient of the Wesolowski Award for Lifetime Achievements in Exposure Science, and is a Distinguished Alumnus in Science, Mathematics and Engineering from the Graduate School of Rutgers University. Currently, he is an associate editor of* Environmental Health Perspectives, *and the vice chair of the National Research Council Committee on Exposure Science in the 21st Century. He is also a co-principal investigator on the Mount Sinai School of Medicine, National Children's Study (NCS) New York--Northern New Jersey Study Center.*

[^2]: Stephen Rappaport is a professor of environmental health at the School of Public Health, University of California, Berkeley, and directs the Berkeley Center for Exposure Biology, a multidisciplinary program to develop a new generation of biomarkers and biosensors for environmental epidemiology. He is a pioneer in the emerging field of exposure biology and a prominent advocate of the concept of the exposome for environmental health. Much of his current research involves the development and application of blood protein adducts as biomarkers of exposure to toxic chemicals arising from inhalation, ingestion, and endogenous processes. He was the 2010 recipient of the Weslowski Award for Lifetime Achievements in Exposure Science.
